| Outcomes | 30 days follow-up |
| Death, n (%) | 4 (1.2%) |
| Cardiac death, n (%) | 4 (1.2%) |
| Non-cardiac death, n (%) | 0 (0) |
| Myocardial infarction, n (%) | 0 (0) |
| Target lesion revascularization, n (%) | 1 (0.3%) |
| Target vessel revascularization, n (%) | 0 (0%) |
| Overall stent thrombosis, n (%) | 1 (0.3%) |
| Definite stent thrombosis, n (%) | 1 (0.3%) |
| Probable stent thrombosis, n (%) | 0 (0%) |
| Possible stent thrombosis, n (%) | 0 (0%) |
| Major adverse cardiac events, n (%) | 5 (1.5%) |